Reduced cardiac efficiency caused by suboptimal synchronization of the heart's normal contraction might contribute to the development of or exacerbate heart failure. Conceptually and in practice ...

Two multicenter trials drew different conclusions about the value of conduction system relative to biventricular pacing for left bundle branch block in heart failure.

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — His bundle pacing as first-line therapy did not improve ECG or echocardiographic parameters ...

There are 4.8 million patients with congestive heart failure (CHF) in the United States as of 2002, with an additional 400,000-700,000 new cases presenting each year. CHF remains the most frequent ...

LOS ANGELES (March 8, 2002) – Patients who suffer from advanced congestive heart failure and heart rhythm abnormalities may qualify to participate in one of two research trials now underway at ...

The findings suggest that use of the pacing technique during CRT should be reserved for expert operators, at least for now.

MINNEAPOLIS - Medtronic, Inc. today announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P. The Viva CRT-P is ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved three quadripolar cardiac resynchronization therapy pacemakers for the treatment of ...

Dublin, Oct. 09, 2019 (GLOBE NEWSWIRE) -- The "Interventional Cardiology: Implantable Pacemaker Products" report has been added to ResearchAndMarkets.com's offering. The global market for implantable ...

With increased recognition of the link between cancer care and heart disease, more studies are evaluating the interconnectedness of cancer survival, chemotherapy, and heart failure (HF) in patients ...